Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn”), a clinical-stage biotechnology company developing medication-assisted treatments...
The study will focus on treatment for four medical conditions. The post EU awards €6.5 million for psychedelic drug trial appeared first on Green Market...
2023— the year that everyone in the psychedelic industry prepared for takeoff. Well, theoretical (but probable) take off. And, just a few weeks before...
Explore how psychedelic-assisted therapy, particularly with psilocybin, offers new, promising avenues for treating nicotine and other addictions.
Highlights: Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing unique medicinal cannabinoid...
Q1 Fiscal 2024 Highlights All financial results are reported in Canadian dollars unless otherwise stated. VANCOUVER, BC, Jan. 15, 2024 /CNW/ – Numinus...
Q1 Fiscal 2024 Highlights All financial results are reported in Canadian dollars unless otherwise stated. VANCOUVER, BC, Jan. 15, 2024 /CNW/ – Numinus...
Explore transformative psychedelic retreats in Spain. Experience self-discovery and growth at Acsauhaya, Rejuvyn, and Avalon in serene, supportive set...
MAPS Public Benefit Corporation (“MAPS PBC”), a company dedicated to transforming mental healthcare, announced an oversubscribed Series A financing....
Sexual abuse during psychedelic treatments continues to be a major issue within the industry. Sexual misconduct does happen during psychedelic treatments,...